Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
1.
Brief Bioinform ; 24(5)2023 09 20.
Article in English | MEDLINE | ID: mdl-37651605

ABSTRACT

MicroRNAs (miRNAs) silence genes by binding to messenger RNAs, whereas long non-coding RNAs (lncRNAs) act as competitive endogenous RNAs (ceRNAs) that can relieve miRNA silencing effects and upregulate target gene expression. The ceRNA association between lncRNAs and miRNAs has been a research hotspot due to its medical importance, but it is challenging to verify experimentally. In this paper, we propose a novel deep learning scheme, i.e. sequence pre-training-based graph neural network (SPGNN), that combines pre-training and fine-tuning stages to predict lncRNA-miRNA associations from RNA sequences and the existing interactions represented as a graph. First, we utilize a sequence-to-vector technique to generate pre-trained embeddings based on the sequences of all RNAs during the pre-training stage. In the fine-tuning stage, we use Graph Neural Network to learn node representations from the heterogeneous graph constructed using lncRNA-miRNA association information. We evaluate our proposed scheme SPGNN on our newly collected animal lncRNA-miRNA association dataset and demonstrate that combining the $k$-mer technique and Doc2vec model for pre-training with the Simple Graph Convolution Network for fine-tuning is effective in predicting lncRNA-miRNA associations. Our approach outperforms state-of-the-art baselines across various evaluation metrics. We also conduct an ablation study and hyperparameter analysis to verify the effectiveness of each component and parameter of our scheme. The complete code and dataset are available on GitHub: https://github.com/zixwang/SPGNN.


Subject(s)
MicroRNAs , RNA, Long Noncoding , Animals , MicroRNAs/genetics , RNA, Long Noncoding/genetics , Benchmarking , Neural Networks, Computer , RNA, Messenger
2.
Anal Biochem ; 673: 115196, 2023 07 15.
Article in English | MEDLINE | ID: mdl-37236434

ABSTRACT

Antimicrobial peptides (AMPs) called host defense peptides have existed among all classes of life with 5-100 amino acids generally and can kill mycobacteria, envelop viruses, bacteria, fungi, cancerous cells and so on. Owing to the non-drug resistance of AMP, it has been a wonderful agent to find novel therapies. Therefore, it is urgent to identify AMPs and predict their function in a high-throughput way. In this paper, we propose a cascaded computational model to identify AMPs and their functional type based on sequence-derived and life language embedding, called AMPFinder. Compared with other state-of-the-art methods, AMPFinder obtains higher performance both on AMP identification and AMP function prediction. AMPFinder shows better performance with improvement of F1-score (1.45%-6.13%), MCC (2.92%-12.86%) and AUC (5.13%-8.56%) and AP (9.20%-21.07%) on an independent test dataset. And AMPFinder achieve lower bias of R2 on a public dataset by 10-fold cross-validation with an improvement of (18.82%-19.46%). The comparison with other state-of-the-art methods shows that AMP can accurately identify AMP and its function types. The datasets, source code and user-friendly application are available at https://github.com/abcair/AMPFinder.


Subject(s)
Antimicrobial Cationic Peptides , Antimicrobial Peptides , Antimicrobial Cationic Peptides/pharmacology , Antimicrobial Cationic Peptides/chemistry , Software , Fungi
3.
Article in English | MEDLINE | ID: mdl-38059127

ABSTRACT

OBJECTIVE: Leveraging patient data through machine learning techniques in disease care offers a multitude of substantial benefits. Nonetheless, the inherent nature of patient data poses several challenges. Prevalent cases amass substantial longitudinal data owing to their patient volume and consistent follow-ups, however, longitudinal laboratory data are renowned for their irregularity, temporality, absenteeism, and sparsity; In contrast, recruitment for rare or specific cases is often constrained due to their limited patient size and episodic observations. This study employed self-supervised learning (SSL) to pretrain a generalized laboratory progress (GLP) model that captures the overall progression of six common laboratory markers in prevalent cardiovascular cases, with the intention of transferring this knowledge to aid in the detection of specific cardiovascular event. METHODS AND PROCEDURES: GLP implemented a two-stage training approach, leveraging the information embedded within interpolated data and amplify the performance of SSL. After GLP pretraining, it is transferred for target vessel revascularization (TVR) detection. RESULTS: The proposed two-stage training improved the performance of pure SSL, and the transferability of GLP exhibited distinctiveness. After GLP processing, the classification exhibited a notable enhancement, with averaged accuracy rising from 0.63 to 0.90. All evaluated metrics demonstrated substantial superiority ([Formula: see text]) compared to prior GLP processing. CONCLUSION: Our study effectively engages in translational engineering by transferring patient progression of cardiovascular laboratory parameters from one patient group to another, transcending the limitations of data availability. The transferability of disease progression optimized the strategies of examinations and treatments, and improves patient prognosis while using commonly available laboratory parameters. The potential for expanding this approach to encompass other diseases holds great promise. CLINICAL IMPACT: Our study effectively transposes patient progression from one cohort to another, surpassing the constraints of episodic observation. The transferability of disease progression contributed to cardiovascular event assessment.


Subject(s)
Absenteeism , Cardiovascular Diseases , Humans , Benchmarking , Cardiovascular Diseases/diagnosis , Disease Progression , Supervised Machine Learning
4.
Diagnostics (Basel) ; 13(19)2023 Sep 25.
Article in English | MEDLINE | ID: mdl-37835785

ABSTRACT

The use of deep learning methods for the automatic detection and quantification of bone metastases in bone scan images holds significant clinical value. A fast and accurate automated system for segmenting bone metastatic lesions can assist clinical physicians in diagnosis. In this study, a small internal dataset comprising 100 breast cancer patients (90 cases of bone metastasis and 10 cases of non-metastasis) and 100 prostate cancer patients (50 cases of bone metastasis and 50 cases of non-metastasis) was used for model training. Initially, all image labels were binary. We used the Otsu thresholding method or negative mining to generate a non-metastasis mask, thereby transforming the image labels into three classes. We adopted the Double U-Net as the baseline model and made modifications to its output activation function. We changed the activation function to SoftMax to accommodate multi-class segmentation. Several methods were used to enhance model performance, including background pre-processing to remove background information, adding negative samples to improve model precision, and using transfer learning to leverage shared features between two datasets, which enhances the model's performance. The performance was investigated via 10-fold cross-validation and computed on a pixel-level scale. The best model we achieved had a precision of 69.96%, a sensitivity of 63.55%, and an F1-score of 66.60%. Compared to the baseline model, this represents an 8.40% improvement in precision, a 0.56% improvement in sensitivity, and a 4.33% improvement in the F1-score. The developed system has the potential to provide pre-diagnostic reports for physicians in final decisions and the calculation of the bone scan index (BSI) with the combination with bone skeleton segmentation.

5.
Patterns (N Y) ; 3(4): 100488, 2022 Apr 08.
Article in English | MEDLINE | ID: mdl-35465225

ABSTRACT

A bottleneck in efficiently connecting new materials discoveries to established literature has arisen due to an increase in publications. This problem may be addressed by using named entity recognition (NER) to extract structured summary-level data from unstructured materials science text. We compare the performance of four NER models on three materials science datasets. The four models include a bidirectional long short-term memory (BiLSTM) and three transformer models (BERT, SciBERT, and MatBERT) with increasing degrees of domain-specific materials science pre-training. MatBERT improves over the other two BERTBASE-based models by 1%∼12%, implying that domain-specific pre-training provides measurable advantages. Despite relative architectural simplicity, the BiLSTM model consistently outperforms BERT, perhaps due to its domain-specific pre-trained word embeddings. Furthermore, MatBERT and SciBERT models outperform the original BERT model to a greater extent in the small data limit. MatBERT's higher-quality predictions should accelerate the extraction of structured data from materials science literature.

6.
Diagnostics (Basel) ; 11(3)2021 Mar 15.
Article in English | MEDLINE | ID: mdl-33803921

ABSTRACT

This study aimed to explore efficient ways to diagnose bone metastasis early using bone scintigraphy images through negative mining, pre-training, the convolutional neural network, and deep learning. We studied 205 prostate cancer patients and 371 breast cancer patients and used bone scintigraphy data from breast cancer patients to pre-train a YOLO v4 with a false-positive reduction strategy. With the pre-trained model, transferred learning was applied to prostate cancer patients to build a model to detect and identify metastasis locations using bone scintigraphy. Ten-fold cross validation was conducted. The mean sensitivity and precision rates for bone metastasis location detection and classification (lesion-based) in the chests of prostate patients were 0.72 ± 0.04 and 0.90 ± 0.04, respectively. The mean sensitivity and specificity rates for bone metastasis classification (patient-based) in the chests of prostate patients were 0.94 ± 0.09 and 0.92 ± 0.09, respectively. The developed system has the potential to provide pre-diagnostic reports to aid in physicians' final decisions.

SELECTION OF CITATIONS
SEARCH DETAIL